Description du livre Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book elaborates on drug delivery targeting via intracellular delivery, specifically through the Receptor Mediated Endocytosis (RME) approach, due to the involvement of cellular receptors in various grave diseases. Targeted delivery relies on two basic approaches, passive and active targeting. While passive targeting approaches have shown great promise, the improved selectivity achieved with active targeting approaches has resulted in significantly higher efficacy. Interestingly there are numerous strategies for active targeting, many of which are already highlighted in ,Targeted Drug Delivery: Concepts and Applications.Nevertheless an exciting and practical strategy for active targeting, which could enable high intracellular delivery, is through exploitation of RME. Cells in the body express receptors to enable various physiological and biochemical processes. As a result, many of these receptors are overexpressed in pathological conditions, or newer receptors expressed due to defectivecellular functioning. RME is based on exploitation of such receptors to achieve intracellular delivery.While targeted delivery can have manifold applications, in this book we focus on two major and challenging therapeutic areas; i) Cancer and ii) Infectious Diseases.Targeted Intracellular Drug Delivery by Receptor Medicated Endocytosisdiscusses the major receptors that are useful for targeted delivery for these afflictions. A major section of this book is dedicated to details regarding their occurrence and location, the recognition domain of the receptor, structure activity relationship of substrate /ligand for selective binding, ligands explored, antagonists for ligand binding and relevance of these aspects for therapy of cancer and infectious diseases. These facets are elucidated with the help of specific examples from academic research and also emphasize commercial products, wherever relevant. In vitro cellular models relied on for assessing receptor mediated cellular targeting and in vivo models depicting clinical efficacy are focused on in a separate section. Finally, we briefly discuss the regulatory and toxicity issues that may be associated specifically with the RME approach of intracellular drug delivery. 580 pp. Englisch. N� de r�f. du vendeur 9783030291679

Plus d'informations sur ce vendeur | Contacter le vendeur

Acheter neuf

EUR 106,99

Autre devise

Ajouter au panier

Frais de port : EUR 23

De Allemagne vers Etats-Unis

Destinations, frais et d�lais

Image fournie par le vendeur

Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis

Devarajan, Padma V.|Dandekar, Prajakta|D\'Souza, Anisha A.

Edit� par Springer International Publishing (2019)

ISBN 10 : 3030291677 ISBN 13 : 9783030291679

Neuf Couverture rigide Quantit� disponible : > 20

impression � la demande

Vendeur :

moluna
(Greven, Allemagne)

Evaluation vendeur

Evaluation du vendeur :

Description du livre Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Unique in that this is the first book focused on one aspect of intracellular delivery that focuses on cancer and infectious diseasesEssential advanced reference on receptor and receptor-mediated drug deliveryProvides research that demonstra. N� de r�f. du vendeur 336485281

Plus d'informations sur ce vendeur | Contacter le vendeur

Acheter neuf

EUR 92,27

Autre devise

Ajouter au panier

Frais de port : EUR 48,99

De Allemagne vers Etats-Unis

Destinations, frais et d�lais

Image fournie par le vendeur

Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis

Padma V. Devarajan

Edit� par Springer International Publishing (2019)

ISBN 10 : 3030291677 ISBN 13 : 9783030291679

Neuf Couverture rigide Quantit� disponible : 1

Vendeur :

AHA-BUCH GmbH
(Einbeck, Allemagne)

Evaluation vendeur

Evaluation du vendeur :

Description du livre Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - This book elaborates on drug delivery targeting via intracellular delivery, specifically through the Receptor Mediated Endocytosis (RME) approach, due to the involvement of cellular receptors in various grave diseases. Targeted delivery relies on two basic approaches, passive and active targeting. While passive targeting approaches have shown great promise, the improved selectivity achieved with active targeting approaches has resulted in significantly higher efficacy. Interestingly there are numerous strategies for active targeting, many of which are already highlighted in ,Targeted Drug Delivery: Concepts and Applications.Nevertheless an exciting and practical strategy for active targeting, which could enable high intracellular delivery, is through exploitation of RME. Cells in the body express receptors to enable various physiological and biochemical processes. As a result, many of these receptors are overexpressed in pathological conditions, or newer receptors expressed due to defectivecellular functioning. RME is based on exploitation of such receptors to achieve intracellular delivery.While targeted delivery can have manifold applications, in this book we focus on two major and challenging therapeutic areas; i) Cancer and ii) Infectious Diseases.Targeted Intracellular Drug Delivery by Receptor Medicated Endocytosisdiscusses the major receptors that are useful for targeted delivery for these afflictions. A major section of this book is dedicated to details regarding their occurrence and location, the recognition domain of the receptor, structure activity relationship of substrate /ligand for selective binding, ligands explored, antagonists for ligand binding and relevance of these aspects for therapy of cancer and infectious diseases. These facets are elucidated with the help of specific examples from academic research and also emphasize commercial products, wherever relevant. In vitro cellular models relied onfor assessing receptor mediated cellular targeting and in vivo models depicting clinical efficacy are focused on in a separate section. Finally, we briefly discuss the regulatory and toxicity issues that may be associated specifically with the RME approach of intracellular drug delivery. N� de r�f. du vendeur 9783030291679

Plus d'informations sur ce vendeur | Contacter le vendeur

Acheter neuf

EUR 111,86

Autre devise

Ajouter au panier

Frais de port : EUR 32,99

De Allemagne vers Etats-Unis

Destinations, frais et d�lais

Image d'archives